Drug, Healthcare and Patient Safety

Aims and Scope

Editor-in-Chief: Professor Rajender Aparasu

Drug, Healthcare and Patient Safety is an international, peer-reviewed, open-access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy, and surgery.

Drug, Healthcare and Patient Safety will no longer consider meta-analyses for publication.

The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological, and post-marketing surveillance studies, risk management, health literacy, and educational programs across all areas of healthcare safety. Also, guidelines on data requirements to assure acceptable safety levels in license applications, post-marketing protocols on monitoring safety, adverse reaction case reports, and managing associated morbidity and mortality are key topics. Drug utilization studies, intervention research, and policy research focusing on healthcare safety are also welcome. Balancing risk, effectiveness, patient satisfaction, quality of life, and the development and testing of new interventions to optimize safety outcomes in disease management are major areas of interest for the journal. Study protocols, animal and in vitro toxicity studies are out of scope for the journal.

Updated 26 September 2025